Compare Walt Disney Co (DIS) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Walt Disney Co vs Regeneron Pharmaceuticals Inc — how do they compare? Walt Disney Co trades at $95.99 (market cap $166.71B), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Walt Disney Co is far larger — about 2.4× Regeneron Pharmaceuticals Inc's market cap, and Walt Disney Co pays the higher dividend (1.56%). Which is the better fit depends on your goals.
| DIS | REGN | |
|---|---|---|
Market Cap | $166.71B | $69.52B |
Volume | 7,546,013 | — |
Sector | Media | Health |
52-Week High | $122.94 | $812.27 |
52-Week Low | $92.40 | $542.52 |
Enterprise Value | $208.38B | $63.47B |
Dividend Yield | 1.56% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Walt Disney Co
The Walt Disney Company is an entertainment company with operations in media networks, park experiences & consumer products, studio entertainment and Direct-to-Consumer networks and channels. The Company serves customers worldwide.
Read more on DIS →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
